Metformin clinical trials

Explore recruiting metformin clinical trials.

Recruiting metformin studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Metformin trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Safety of Lanreotide 120 mg ATG in combination with Metformin in patients with progressive advanced Well-differentiated gastro-intestinal (GI) or lung carcinoids. A pilot, one-arm, open-label, prospective study: the MetNET-2 trial

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

A double blinded, phase II, placebo controlled, single centre randomized clinical trial to evaluate Metformin compared with placebo for reversal of accelerated biological aging in persons living with HIV 50 years or older and with suppressed virologic replication.

Spain

Phase I and Phase II (Integrated)- Bioequivalence Study EU CTIS Study details

Metformin for Abdominal Aortic Aneurysm Inhibition (MAAAGI) A randomized controlled trial

Sweden, Netherlands, Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A Multicentre, Randomized, Double-blind, Placebo-controlled, phase III study to evaluate the efficacy and safety of Pioglitazone co-administration in patients with type II diabetes with insufficient glycemic control with Metformin and Empagliflozin combination therapy

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Impact of Metformin on Peripheral Arterial Calcification in Type 1 Diabetes (IMPACT-1D)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Metformin Intervention in children and adolescents with obesity. A parallel, three arms, randomized, 6 months, multi-center study with metformin extended release (XR) plus lifestyle or metformin immediate release (IR) plus lifestyle or lifestyle alone.

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Metformin trials by city

Metformin in Toronto Metformin in Vancouver Metformin in Montreal Metformin in Calgary Metformin in Edmonton Metformin in Ottawa Metformin in Winnipeg Metformin in Quebec City Metformin in Hamilton Metformin in Kitchener Metformin in London Metformin in Halifax Metformin in New York Metformin in Los Angeles Metformin in Chicago Metformin in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease